ArticleFrontiers in pediatrics2014

SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.

Eva Rettinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.